Epstein–Barr Virus, but not human Papillomavirus, is associated with preinvasive and invasive ocular surface squamous neoplasias in Zambian patients

Autores
Julius, Peter; Siyumbwa, Stepfanie N.; Moonga, Phyllis; Maate, Fred; Kaile, Trevor; Haynatski, Gleb; Minhas, Veenu; Snow, Jazmine; Peterson, Kerstin; Gihozo, Patience; Streeter, Sam; Kaur, Salan; Evans, Annika; Gonzalez, Daniela del Carmen; Samwel, Kandali; Kang, Guobin; West, John T.; Wood, Charles; Angeletti, Peter C.
Año de publicación
2022
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Background: The etiopathogenesis of ocular surface squamous neoplasia (OSSN) is not fully understood. We assessed the frequency of oncogenic viruses in OSSN by immunohistochemistry (IHC) and polymerase chain reaction (PCR) for human papillomavirus (HPV), Epstein–Barr virus (EBV), Merkel cell polyomavirus (MCPyV), Kaposi sarcoma virus, and adenovirus. Cases from Zambia were prospectively enrolled using a cross-sectional study design between November 2017 and March 2020. Methods: Demographic and clinical data [age, sex, HIV status, antiretroviral therapy (ART) history, CD4 count, plasma viral load] and tumor biopsies were collected from 243 consenting patients. Tumor samples were bisected, and half was used for DNA isolation, while the other half was formalin fixed and paraffin embedded (FFPE) for histopathology analysis. The expressions of latent EBV nuclear antigen 1 (EBNA1), CDKN2A/p16INK4A (p16), and MCPyV large T-antigen (LT) were tested by IHC. Multiplex PCR was used to detect 16 HPV genotypes and four other DNA tumor viruses [Kaposi’s sarcomaassociated herpesvirus (KSHV), EBV, MCPyV, and adenovirus]. Relationships between HIV status, viral DNA and protein expression, and tumor grades were determined by statistical analysis. Results: OSSN tumors from patients were 29.6% preinvasive and 70.4% invasive. Patients presented with unilateral tumors that were 70.4% late stage (T3/T4). OSSN patients were HIV positive (72.8%). IHC on 243 FFPE biopsies resulted in the detection of EBNA1 (EBV), p16 high-risk HPV (HR-HPV), and MCPyV LT expression in 89.0%, 4.9%, and 0.0%, respectively. EBNA1 was expressed in all grades of preinvasive [corneaconjunctiva intraepithelial neoplasia (CIN)1, 100%; CIN2, 85.7%; CIN3, 95.8%; and carcinoma in situ (CIS), 83.8%] and in invasive (89.2%) OSSN. PCR on 178 samples detected EBV, HR-HPV, and MCPyV in 80.3%, 9.0%, and 13.5% of tumors, respectively. EBV was detected in all grades of preinvasive and invasive OSSN. EBV detection was associated with high HIV viral loads (p = 0.022). HR-HPV was detected in 0.0% CIN1, 0.0% CIN2, 5.6% CIN3, 13.0% CIS, and 7.0% invasive OSSN. Conclusions: Our findings of EBV DNA and EBNA1 protein in all the grades of preinvasive and especially invasive OSSN are consistent with a potential causal role for EBV in OSSN. A role of HPV in OSSN was not clearly established in this study.
Fil: Julius, Peter. School of Medicine. Department of Pathology and Microbiology; Zambia
Fil: Siyumbwa, Stepfanie N.. School of Medicine. Department of Pathology and Microbiology; Zambia
Fil: Moonga, Phyllis. University Teaching Hospital; Zambia
Fil: Maate, Fred. School of Medicine. Department of Pathology and Microbiology; Zambia
Fil: Kaile, Trevor. School of Medicine. Department of Pathology and Microbiology; Zambia
Fil: Haynatski, Gleb. University of Nebraska Medical Center. Department of Biostatistics; Estados Unidos
Fil: Minhas, Veenu. University of Nebraska Medical Center. Department of Biostatistics; Estados Unidos
Fil: Snow, Jazmine. Universidad de Nebraska - Lincoln; Estados Unidos
Fil: Peterson, Kerstin. Universidad de Nebraska - Lincoln; Estados Unidos
Fil: Gihozo, Patience. Universidad de Nebraska - Lincoln; Estados Unidos
Fil: Streeter, Sam. Universidad de Nebraska - Lincoln; Estados Unidos
Fil: Kaur, Salan. Universidad de Nebraska - Lincoln; Estados Unidos
Fil: Evans, Annika. Universidad de Nebraska - Lincoln; Estados Unidos
Fil: Gonzalez, Daniela del Carmen. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - San Juan; Argentina. Universidad de Nebraska - Lincoln; Estados Unidos
Fil: Samwel, Kandali. Ocean Road Cancer Institute; Tanzania
Fil: Kang, Guobin. Louisiana State University Health Science Center; Estados Unidos
Fil: West, John T.. Louisiana State University Health Science Center; Estados Unidos
Fil: Wood, Charles. Louisiana State University Health Science Center; Estados Unidos
Fil: Angeletti, Peter C.. Universidad de Nebraska - Lincoln; Estados Unidos
Materia
OCULAR SURFACE SQUAMOUS NEOPLASIA
HUMAN PAPILLOMA VIRUS
EPSTEIN-BARR VIRUS
ZAMBIA
HUMAN IMMUNODEFICIENCY VIRUS
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/160336

id CONICETDig_ec65cc4f276a48290653d931c96f7372
oai_identifier_str oai:ri.conicet.gov.ar:11336/160336
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Epstein–Barr Virus, but not human Papillomavirus, is associated with preinvasive and invasive ocular surface squamous neoplasias in Zambian patientsJulius, PeterSiyumbwa, Stepfanie N.Moonga, PhyllisMaate, FredKaile, TrevorHaynatski, GlebMinhas, VeenuSnow, JazminePeterson, KerstinGihozo, PatienceStreeter, SamKaur, SalanEvans, AnnikaGonzalez, Daniela del CarmenSamwel, KandaliKang, GuobinWest, John T.Wood, CharlesAngeletti, Peter C.OCULAR SURFACE SQUAMOUS NEOPLASIAHUMAN PAPILLOMA VIRUSEPSTEIN-BARR VIRUSZAMBIAHUMAN IMMUNODEFICIENCY VIRUShttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Background: The etiopathogenesis of ocular surface squamous neoplasia (OSSN) is not fully understood. We assessed the frequency of oncogenic viruses in OSSN by immunohistochemistry (IHC) and polymerase chain reaction (PCR) for human papillomavirus (HPV), Epstein–Barr virus (EBV), Merkel cell polyomavirus (MCPyV), Kaposi sarcoma virus, and adenovirus. Cases from Zambia were prospectively enrolled using a cross-sectional study design between November 2017 and March 2020. Methods: Demographic and clinical data [age, sex, HIV status, antiretroviral therapy (ART) history, CD4 count, plasma viral load] and tumor biopsies were collected from 243 consenting patients. Tumor samples were bisected, and half was used for DNA isolation, while the other half was formalin fixed and paraffin embedded (FFPE) for histopathology analysis. The expressions of latent EBV nuclear antigen 1 (EBNA1), CDKN2A/p16INK4A (p16), and MCPyV large T-antigen (LT) were tested by IHC. Multiplex PCR was used to detect 16 HPV genotypes and four other DNA tumor viruses [Kaposi’s sarcomaassociated herpesvirus (KSHV), EBV, MCPyV, and adenovirus]. Relationships between HIV status, viral DNA and protein expression, and tumor grades were determined by statistical analysis. Results: OSSN tumors from patients were 29.6% preinvasive and 70.4% invasive. Patients presented with unilateral tumors that were 70.4% late stage (T3/T4). OSSN patients were HIV positive (72.8%). IHC on 243 FFPE biopsies resulted in the detection of EBNA1 (EBV), p16 high-risk HPV (HR-HPV), and MCPyV LT expression in 89.0%, 4.9%, and 0.0%, respectively. EBNA1 was expressed in all grades of preinvasive [corneaconjunctiva intraepithelial neoplasia (CIN)1, 100%; CIN2, 85.7%; CIN3, 95.8%; and carcinoma in situ (CIS), 83.8%] and in invasive (89.2%) OSSN. PCR on 178 samples detected EBV, HR-HPV, and MCPyV in 80.3%, 9.0%, and 13.5% of tumors, respectively. EBV was detected in all grades of preinvasive and invasive OSSN. EBV detection was associated with high HIV viral loads (p = 0.022). HR-HPV was detected in 0.0% CIN1, 0.0% CIN2, 5.6% CIN3, 13.0% CIS, and 7.0% invasive OSSN. Conclusions: Our findings of EBV DNA and EBNA1 protein in all the grades of preinvasive and especially invasive OSSN are consistent with a potential causal role for EBV in OSSN. A role of HPV in OSSN was not clearly established in this study.Fil: Julius, Peter. School of Medicine. Department of Pathology and Microbiology; ZambiaFil: Siyumbwa, Stepfanie N.. School of Medicine. Department of Pathology and Microbiology; ZambiaFil: Moonga, Phyllis. University Teaching Hospital; ZambiaFil: Maate, Fred. School of Medicine. Department of Pathology and Microbiology; ZambiaFil: Kaile, Trevor. School of Medicine. Department of Pathology and Microbiology; ZambiaFil: Haynatski, Gleb. University of Nebraska Medical Center. Department of Biostatistics; Estados UnidosFil: Minhas, Veenu. University of Nebraska Medical Center. Department of Biostatistics; Estados UnidosFil: Snow, Jazmine. Universidad de Nebraska - Lincoln; Estados UnidosFil: Peterson, Kerstin. Universidad de Nebraska - Lincoln; Estados UnidosFil: Gihozo, Patience. Universidad de Nebraska - Lincoln; Estados UnidosFil: Streeter, Sam. Universidad de Nebraska - Lincoln; Estados UnidosFil: Kaur, Salan. Universidad de Nebraska - Lincoln; Estados UnidosFil: Evans, Annika. Universidad de Nebraska - Lincoln; Estados UnidosFil: Gonzalez, Daniela del Carmen. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - San Juan; Argentina. Universidad de Nebraska - Lincoln; Estados UnidosFil: Samwel, Kandali. Ocean Road Cancer Institute; TanzaniaFil: Kang, Guobin. Louisiana State University Health Science Center; Estados UnidosFil: West, John T.. Louisiana State University Health Science Center; Estados UnidosFil: Wood, Charles. Louisiana State University Health Science Center; Estados UnidosFil: Angeletti, Peter C.. Universidad de Nebraska - Lincoln; Estados UnidosFrontiers Media2022-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/160336Julius, Peter; Siyumbwa, Stepfanie N.; Moonga, Phyllis; Maate, Fred; Kaile, Trevor; et al.; Epstein–Barr Virus, but not human Papillomavirus, is associated with preinvasive and invasive ocular surface squamous neoplasias in Zambian patients; Frontiers Media; Frontiers in Oncology; 12; 4-2022; 1-152234-943XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.frontiersin.org/articles/10.3389/fonc.2022.864066/fullinfo:eu-repo/semantics/altIdentifier/doi/10.3389/fonc.2022.864066info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-22T11:46:04Zoai:ri.conicet.gov.ar:11336/160336instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-22 11:46:04.949CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Epstein–Barr Virus, but not human Papillomavirus, is associated with preinvasive and invasive ocular surface squamous neoplasias in Zambian patients
title Epstein–Barr Virus, but not human Papillomavirus, is associated with preinvasive and invasive ocular surface squamous neoplasias in Zambian patients
spellingShingle Epstein–Barr Virus, but not human Papillomavirus, is associated with preinvasive and invasive ocular surface squamous neoplasias in Zambian patients
Julius, Peter
OCULAR SURFACE SQUAMOUS NEOPLASIA
HUMAN PAPILLOMA VIRUS
EPSTEIN-BARR VIRUS
ZAMBIA
HUMAN IMMUNODEFICIENCY VIRUS
title_short Epstein–Barr Virus, but not human Papillomavirus, is associated with preinvasive and invasive ocular surface squamous neoplasias in Zambian patients
title_full Epstein–Barr Virus, but not human Papillomavirus, is associated with preinvasive and invasive ocular surface squamous neoplasias in Zambian patients
title_fullStr Epstein–Barr Virus, but not human Papillomavirus, is associated with preinvasive and invasive ocular surface squamous neoplasias in Zambian patients
title_full_unstemmed Epstein–Barr Virus, but not human Papillomavirus, is associated with preinvasive and invasive ocular surface squamous neoplasias in Zambian patients
title_sort Epstein–Barr Virus, but not human Papillomavirus, is associated with preinvasive and invasive ocular surface squamous neoplasias in Zambian patients
dc.creator.none.fl_str_mv Julius, Peter
Siyumbwa, Stepfanie N.
Moonga, Phyllis
Maate, Fred
Kaile, Trevor
Haynatski, Gleb
Minhas, Veenu
Snow, Jazmine
Peterson, Kerstin
Gihozo, Patience
Streeter, Sam
Kaur, Salan
Evans, Annika
Gonzalez, Daniela del Carmen
Samwel, Kandali
Kang, Guobin
West, John T.
Wood, Charles
Angeletti, Peter C.
author Julius, Peter
author_facet Julius, Peter
Siyumbwa, Stepfanie N.
Moonga, Phyllis
Maate, Fred
Kaile, Trevor
Haynatski, Gleb
Minhas, Veenu
Snow, Jazmine
Peterson, Kerstin
Gihozo, Patience
Streeter, Sam
Kaur, Salan
Evans, Annika
Gonzalez, Daniela del Carmen
Samwel, Kandali
Kang, Guobin
West, John T.
Wood, Charles
Angeletti, Peter C.
author_role author
author2 Siyumbwa, Stepfanie N.
Moonga, Phyllis
Maate, Fred
Kaile, Trevor
Haynatski, Gleb
Minhas, Veenu
Snow, Jazmine
Peterson, Kerstin
Gihozo, Patience
Streeter, Sam
Kaur, Salan
Evans, Annika
Gonzalez, Daniela del Carmen
Samwel, Kandali
Kang, Guobin
West, John T.
Wood, Charles
Angeletti, Peter C.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv OCULAR SURFACE SQUAMOUS NEOPLASIA
HUMAN PAPILLOMA VIRUS
EPSTEIN-BARR VIRUS
ZAMBIA
HUMAN IMMUNODEFICIENCY VIRUS
topic OCULAR SURFACE SQUAMOUS NEOPLASIA
HUMAN PAPILLOMA VIRUS
EPSTEIN-BARR VIRUS
ZAMBIA
HUMAN IMMUNODEFICIENCY VIRUS
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Background: The etiopathogenesis of ocular surface squamous neoplasia (OSSN) is not fully understood. We assessed the frequency of oncogenic viruses in OSSN by immunohistochemistry (IHC) and polymerase chain reaction (PCR) for human papillomavirus (HPV), Epstein–Barr virus (EBV), Merkel cell polyomavirus (MCPyV), Kaposi sarcoma virus, and adenovirus. Cases from Zambia were prospectively enrolled using a cross-sectional study design between November 2017 and March 2020. Methods: Demographic and clinical data [age, sex, HIV status, antiretroviral therapy (ART) history, CD4 count, plasma viral load] and tumor biopsies were collected from 243 consenting patients. Tumor samples were bisected, and half was used for DNA isolation, while the other half was formalin fixed and paraffin embedded (FFPE) for histopathology analysis. The expressions of latent EBV nuclear antigen 1 (EBNA1), CDKN2A/p16INK4A (p16), and MCPyV large T-antigen (LT) were tested by IHC. Multiplex PCR was used to detect 16 HPV genotypes and four other DNA tumor viruses [Kaposi’s sarcomaassociated herpesvirus (KSHV), EBV, MCPyV, and adenovirus]. Relationships between HIV status, viral DNA and protein expression, and tumor grades were determined by statistical analysis. Results: OSSN tumors from patients were 29.6% preinvasive and 70.4% invasive. Patients presented with unilateral tumors that were 70.4% late stage (T3/T4). OSSN patients were HIV positive (72.8%). IHC on 243 FFPE biopsies resulted in the detection of EBNA1 (EBV), p16 high-risk HPV (HR-HPV), and MCPyV LT expression in 89.0%, 4.9%, and 0.0%, respectively. EBNA1 was expressed in all grades of preinvasive [corneaconjunctiva intraepithelial neoplasia (CIN)1, 100%; CIN2, 85.7%; CIN3, 95.8%; and carcinoma in situ (CIS), 83.8%] and in invasive (89.2%) OSSN. PCR on 178 samples detected EBV, HR-HPV, and MCPyV in 80.3%, 9.0%, and 13.5% of tumors, respectively. EBV was detected in all grades of preinvasive and invasive OSSN. EBV detection was associated with high HIV viral loads (p = 0.022). HR-HPV was detected in 0.0% CIN1, 0.0% CIN2, 5.6% CIN3, 13.0% CIS, and 7.0% invasive OSSN. Conclusions: Our findings of EBV DNA and EBNA1 protein in all the grades of preinvasive and especially invasive OSSN are consistent with a potential causal role for EBV in OSSN. A role of HPV in OSSN was not clearly established in this study.
Fil: Julius, Peter. School of Medicine. Department of Pathology and Microbiology; Zambia
Fil: Siyumbwa, Stepfanie N.. School of Medicine. Department of Pathology and Microbiology; Zambia
Fil: Moonga, Phyllis. University Teaching Hospital; Zambia
Fil: Maate, Fred. School of Medicine. Department of Pathology and Microbiology; Zambia
Fil: Kaile, Trevor. School of Medicine. Department of Pathology and Microbiology; Zambia
Fil: Haynatski, Gleb. University of Nebraska Medical Center. Department of Biostatistics; Estados Unidos
Fil: Minhas, Veenu. University of Nebraska Medical Center. Department of Biostatistics; Estados Unidos
Fil: Snow, Jazmine. Universidad de Nebraska - Lincoln; Estados Unidos
Fil: Peterson, Kerstin. Universidad de Nebraska - Lincoln; Estados Unidos
Fil: Gihozo, Patience. Universidad de Nebraska - Lincoln; Estados Unidos
Fil: Streeter, Sam. Universidad de Nebraska - Lincoln; Estados Unidos
Fil: Kaur, Salan. Universidad de Nebraska - Lincoln; Estados Unidos
Fil: Evans, Annika. Universidad de Nebraska - Lincoln; Estados Unidos
Fil: Gonzalez, Daniela del Carmen. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - San Juan; Argentina. Universidad de Nebraska - Lincoln; Estados Unidos
Fil: Samwel, Kandali. Ocean Road Cancer Institute; Tanzania
Fil: Kang, Guobin. Louisiana State University Health Science Center; Estados Unidos
Fil: West, John T.. Louisiana State University Health Science Center; Estados Unidos
Fil: Wood, Charles. Louisiana State University Health Science Center; Estados Unidos
Fil: Angeletti, Peter C.. Universidad de Nebraska - Lincoln; Estados Unidos
description Background: The etiopathogenesis of ocular surface squamous neoplasia (OSSN) is not fully understood. We assessed the frequency of oncogenic viruses in OSSN by immunohistochemistry (IHC) and polymerase chain reaction (PCR) for human papillomavirus (HPV), Epstein–Barr virus (EBV), Merkel cell polyomavirus (MCPyV), Kaposi sarcoma virus, and adenovirus. Cases from Zambia were prospectively enrolled using a cross-sectional study design between November 2017 and March 2020. Methods: Demographic and clinical data [age, sex, HIV status, antiretroviral therapy (ART) history, CD4 count, plasma viral load] and tumor biopsies were collected from 243 consenting patients. Tumor samples were bisected, and half was used for DNA isolation, while the other half was formalin fixed and paraffin embedded (FFPE) for histopathology analysis. The expressions of latent EBV nuclear antigen 1 (EBNA1), CDKN2A/p16INK4A (p16), and MCPyV large T-antigen (LT) were tested by IHC. Multiplex PCR was used to detect 16 HPV genotypes and four other DNA tumor viruses [Kaposi’s sarcomaassociated herpesvirus (KSHV), EBV, MCPyV, and adenovirus]. Relationships between HIV status, viral DNA and protein expression, and tumor grades were determined by statistical analysis. Results: OSSN tumors from patients were 29.6% preinvasive and 70.4% invasive. Patients presented with unilateral tumors that were 70.4% late stage (T3/T4). OSSN patients were HIV positive (72.8%). IHC on 243 FFPE biopsies resulted in the detection of EBNA1 (EBV), p16 high-risk HPV (HR-HPV), and MCPyV LT expression in 89.0%, 4.9%, and 0.0%, respectively. EBNA1 was expressed in all grades of preinvasive [corneaconjunctiva intraepithelial neoplasia (CIN)1, 100%; CIN2, 85.7%; CIN3, 95.8%; and carcinoma in situ (CIS), 83.8%] and in invasive (89.2%) OSSN. PCR on 178 samples detected EBV, HR-HPV, and MCPyV in 80.3%, 9.0%, and 13.5% of tumors, respectively. EBV was detected in all grades of preinvasive and invasive OSSN. EBV detection was associated with high HIV viral loads (p = 0.022). HR-HPV was detected in 0.0% CIN1, 0.0% CIN2, 5.6% CIN3, 13.0% CIS, and 7.0% invasive OSSN. Conclusions: Our findings of EBV DNA and EBNA1 protein in all the grades of preinvasive and especially invasive OSSN are consistent with a potential causal role for EBV in OSSN. A role of HPV in OSSN was not clearly established in this study.
publishDate 2022
dc.date.none.fl_str_mv 2022-04
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/160336
Julius, Peter; Siyumbwa, Stepfanie N.; Moonga, Phyllis; Maate, Fred; Kaile, Trevor; et al.; Epstein–Barr Virus, but not human Papillomavirus, is associated with preinvasive and invasive ocular surface squamous neoplasias in Zambian patients; Frontiers Media; Frontiers in Oncology; 12; 4-2022; 1-15
2234-943X
CONICET Digital
CONICET
url http://hdl.handle.net/11336/160336
identifier_str_mv Julius, Peter; Siyumbwa, Stepfanie N.; Moonga, Phyllis; Maate, Fred; Kaile, Trevor; et al.; Epstein–Barr Virus, but not human Papillomavirus, is associated with preinvasive and invasive ocular surface squamous neoplasias in Zambian patients; Frontiers Media; Frontiers in Oncology; 12; 4-2022; 1-15
2234-943X
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://www.frontiersin.org/articles/10.3389/fonc.2022.864066/full
info:eu-repo/semantics/altIdentifier/doi/10.3389/fonc.2022.864066
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Frontiers Media
publisher.none.fl_str_mv Frontiers Media
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1846782160728489984
score 12.982451